Analyzing long-term survival after enhanced recovery for colorectal cancer surgery
Surgical Treatment of Colorectal Cancer: Analysis of the Influence of an Enhanced Recovery Protocol on Long-term Oncological Outcomes.
This study is testing if a special recovery program can help people survive longer after surgery for colorectal cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 750 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Grupo Español de Rehabilitación Multimodal Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 12 sites (Elche, Alicante and 11 other locations) |
| Trial ID | NCT04305314 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the impact of an enhanced recovery program (PRI) on three-year survival rates following radical surgery for colorectal cancer. It is a multicentric prospective cohort study involving patients over 18 years scheduled for colorectal surgery at selected hospitals with a minimum PRI implementation level of 70%. The study will analyze compliance with key performance indicators and assess oncological outcomes such as overall survival, cancer-specific survival, and relapse-free survival, alongside quality of life measures.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years scheduled for elective colorectal cancer surgery who meet the inclusion criteria.
Not a fit: Patients requiring urgent surgery, those with stage IV cancer, or individuals with other concomitant surgical processes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve long-term survival rates and quality of life for patients undergoing colorectal cancer surgery.
How similar studies have performed: Previous studies have shown positive outcomes with enhanced recovery protocols in surgical settings, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients over 18 years of age who will be operated on a scheduled basis for colorectal cancer Exclusion Criteria: * - Urgent surgery; -Existence of other concomitant surgical processes; -Patients diagnosed in stage IV cancer; -Patients who refuse to participate.
Where this trial is running
Elche, Alicante and 11 other locations
- Hospital General Universitario de Elche — Elche, Alicante, Spain (Recruiting)
- Complejo Hospitalario de Navarra — Pamplona, Navarra, Spain (Recruiting)
- Hospital de la Ribera — Alzira, Spain (Recruiting)
- Hospital de Barbastro — Barbastro, Spain (Recruiting)
- Hospital Universitario de Guadalajara — Guadalajara, Spain (Recruiting)
- Hospital General Universitario Gregorio Marañón — Madrid, Spain (Recruiting)
- Hospital Jiménez Diaz — Madrid, Spain (Recruiting)
- Hospital Universitario Infanta Leonor — Madrid, Spain (Recruiting)
- Complejo Asistencial Universitario de Palencia — Palencia, Spain (Recruiting)
- Hospital General de Valencia — Valencia, Spain (Recruiting)
- Hospital Clínico Universitario Lozano Blesa — Zaragoza, Spain (Recruiting)
- Hospital Universitario Miguel Servet — Zaragoza, Spain (Recruiting)
Study contacts
- Principal investigator: Jose M Ramirez, Prof. — Universidad de Zaragoza
- Study coordinator: Jose M Ramirez
- Email: jramirez@unizar.es
- Phone: 639776364
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.